{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:24:27Z","timestamp":1780701867277,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.reprotox.2009.02.004","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T05:33:22Z","timestamp":1235540002000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Angiotensin II receptor blockers in pregnancy: A report of five cases"],"prefix":"10.1016","volume":"28","author":[{"given":"Ksenija","family":"Gersak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cvijic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilijana Kornhauser","family":"Cerar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9253","key":"10.1016\/j.reprotox.2009.02.004_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","article-title":"Losartan and fetal toxic effects [letter]","volume":"357","author":"Saji","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.004_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10641950601147937","article-title":"Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature","volume":"26","author":"Vel\u00e1zquez-Armenta","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.reprotox.2009.02.004_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2006-947162","article-title":"Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant","volume":"23","author":"Bass","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.reprotox.2009.02.004_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1471-0528.2004.00525.x","article-title":"Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases","volume":"112","author":"Serreau","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2009.02.004_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1345\/aph.1E250","article-title":"Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth","volume":"39","author":"Bos-Thompson","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.reprotox.2009.02.004_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/BF02730601","article-title":"Losartan induced fetal toxicity","volume":"70","author":"Nayar","year":"2003","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.004_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bdra.20047","article-title":"Fetal toxicity of valsartan and possible reversible adverse side effects","volume":"70","author":"Berkane","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2009.02.004_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1345\/aph.1A013","article-title":"Fatal fetal outcome with the combined use of valsartan and atenolol","volume":"35","author":"Briggs","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.reprotox.2009.02.004_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/bdra.10081","article-title":"Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity","volume":"67","author":"Schaefer","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2009.02.004_bib10","unstructured":"http:\/\/www.who.int\/classifications\/icd\/en\/. [accessed May 10, 2008]."},{"issue":"9268","key":"10.1016\/j.reprotox.2009.02.004_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(00)04758-9","article-title":"Angiotensin-II-receptor inhibitors in pregnancy [letter]","volume":"357","author":"Hinsberger","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.004_bib12","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reprotox.2009.02.004_bib13","series-title":"The developing human: clinically oriented embryology","author":"Moore","year":"2008"},{"key":"10.1016\/j.reprotox.2009.02.004_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00467-006-0070-1","article-title":"Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists","volume":"21","author":"Da\u00efkha-Dahmane","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.reprotox.2009.02.004_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14767050500217244","article-title":"Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists","volume":"18","author":"Vendemmia","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9277","key":"10.1016\/j.reprotox.2009.02.004_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(01)05426-5","article-title":"Fetal toxic effects and angiotensin-II-receptor antagonists [letter]","volume":"358","author":"Martinovic","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.004_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.jp.7210871","article-title":"Neonatal acute renal failure secondary to maternal exposure to telmisartan, angiotensin II receptor antagonist","volume":"23","author":"Pietrement","year":"2003","journal-title":"J Perinatol"},{"issue":"7989","key":"10.1016\/j.reprotox.2009.02.004_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","article-title":"Fetal outcome in trial of antihypertensive treatment in pregnancy","volume":"2","author":"Redman","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.reprotox.2009.02.004_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-0528.2000.tb13222.x","article-title":"Nifedipine in pregnancy","volume":"107","author":"Smith","year":"2000","journal-title":"BJOG"},{"issue":"5 Suppl.","key":"10.1016\/j.reprotox.2009.02.004_bib20","first-page":"52S","article-title":"Neonatal intracranial haemorrhage and maternal use of aspirin","volume":"58","author":"Rumack","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"8898","key":"10.1016\/j.reprotox.2009.02.004_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.004_bib22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1471-0528.2008.01844.x","article-title":"The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women","volume":"115","author":"Zetterstr\u00f6m","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2009.02.004_bib23","first-page":"1046","article-title":"Pregnancy outcomes in women with chronic hypertension: a population-based study","volume":"52","author":"Gilbert","year":"2007","journal-title":"Reprod Med"},{"issue":"406","key":"10.1016\/j.reprotox.2009.02.004_bib24","first-page":"e1","article-title":"Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation","volume":"197","author":"Habli","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623809000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623809000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:46Z","timestamp":1760189266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623809000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0890623809000343"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2009.02.004","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II receptor blockers in pregnancy: A report of five cases","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2009.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}